Showing results (81-90 of 120) with videos related to
Sort By:
Pageof 12
Clinical Cardiology|May 15, 2020
Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT-AF/VTE studyPaolo Colonna, Christian von Heymann, Amparo Santamaria, et al.BDJ Open|August 14, 2023
Edoxaban use in the context of dental procedures: analysis from the EMIT-AF/VTE databaseCathy Chen, Manish Saxena, Christian von Heymann, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|May 4, 2010
Continued persistence of a single genotype of dengue virus type-3 (DENV-3) in Delhi, India since its re-emergence over the last decadeHimani Kukreti, Veena Mittal, Artee Chaudhary, et al.Cancer Reports (Hoboken, N.J.)|June 28, 2021
Shared care for children with cancer in India through social and healthcare partnerships during the COVID-19 pandemicAmita Mahajan, Ramandeep Singh Arora, Puneet Kaur Sahi, et al.Thrombosis Journal|December 15, 2023
Management of edoxaban therapy and clinical outcomes in patients undergoing major or nonmajor surgery: a subanalysis of the EMIT-AF/VTE studyChristian von Heymann, Martin Unverdorben, Paolo Colonna, et al.European Heart Journal. Digital Health|January 30, 2023
Using social media to recruit study participants for a randomized trial for hypertensionLida Feyz, Yale Wang, Atul Pathak, et al.JAMA|February 16, 2024
RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical TrialGeorge L Bakris, Manish Saxena, Anil Gupta, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 27, 2024
36-month durability of ultrasound renal denervation for hypertension resistant to combination therapy in RADIANCE-HTN TRIOMichael J Bloch, Ajay J Kirtane, Michel Azizi, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 1, 2022
Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trialFlorian Rader, Ajay J Kirtane, Yale Wang, et al.JAMA|May 28, 2025
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical TrialAkshay S Desai, Adam D Karns, Jolita Badariene, et al.Pageof 12